Otonomy to Report Third Quarter 2017 Financial Results and Provide Corporate Update

Back to Jobs

Webcast and Conference Call to be Held at 4:30 p.m. EST on November 8, 2017 SAN DIEGO , Nov. 01, 2017 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear,

Apply Now